Poop pills? fecal transplant trial targets IBS sufferers
NCT ID NCT05776914
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 24 times
Summary
This study tests whether a fecal transplant from a carefully selected donor can reduce symptoms in people with moderate to severe irritable bowel syndrome (IBS) who have diarrhea. The donor stool has low levels of certain proteins and contains a specific bacteria. The main goal is to see if this treatment lowers IBS symptom scores by at least 50 points over 12 weeks. About 43 adults with IBS will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Minnesota
RECRUITINGRochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.